[ET Net News Agency, 26 August 2019] Sinopharm Group Co. Ltd. (01099) said its profit
attributable to owners of the parent was RMB2.98 billion for the six months ended 30 June
2019, a year-on-year increase of 6.33%. The earnings per share were RMB1. No dividend will
be distributed.
The revenue was RMB201.67 billion, a year-on-year increase of 23.36%. The gross profit
was RMB17.48 billion, a year-on-year increase of 20.9%. (RC)